Therapeutic Nuclear Medicines-South America Market Status and Trend Report 2013-2023
Report Summary
Therapeutic Nuclear Medicines-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main market players of Therapeutic Nuclear Medicines in South America, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the South America Therapeutic Nuclear Medicines market as:
South America Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America Therapeutic Nuclear Medicines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
South America Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
South America Therapeutic Nuclear Medicines Market: Players Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Therapeutic Nuclear Medicines-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main market players of Therapeutic Nuclear Medicines in South America, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the South America Therapeutic Nuclear Medicines market as:
South America Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America Therapeutic Nuclear Medicines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
South America Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
South America Therapeutic Nuclear Medicines Market: Players Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF THERAPEUTIC NUCLEAR MEDICINES
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 South America Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Therapeutic Nuclear Medicines in South America 2013-2017
2.2 Consumption Market of Therapeutic Nuclear Medicines in South America by Regions
2.2.1 Consumption Volume of Therapeutic Nuclear Medicines in South America by Regions
2.2.2 Revenue of Therapeutic Nuclear Medicines in South America by Regions
2.3 Market Analysis of Therapeutic Nuclear Medicines in South America by Regions
2.3.1 Market Analysis of Therapeutic Nuclear Medicines in Brazil 2013-2017
2.3.2 Market Analysis of Therapeutic Nuclear Medicines in Argentina 2013-2017
2.3.3 Market Analysis of Therapeutic Nuclear Medicines in Venezuela 2013-2017
2.3.4 Market Analysis of Therapeutic Nuclear Medicines in Colombia 2013-2017
2.3.5 Market Analysis of Therapeutic Nuclear Medicines in Others 2013-2017
2.4 Market Development Forecast of Therapeutic Nuclear Medicines in South America 2018-2023
2.4.1 Market Development Forecast of Therapeutic Nuclear Medicines in South America 2018-2023
2.4.2 Market Development Forecast of Therapeutic Nuclear Medicines by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Therapeutic Nuclear Medicines in South America by Types
3.1.2 Revenue of Therapeutic Nuclear Medicines in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Therapeutic Nuclear Medicines in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Therapeutic Nuclear Medicines in South America by Downstream Industry
4.2 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Brazil
4.2.2 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Argentina
4.2.3 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Venezuela
4.2.4 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Colombia
4.2.5 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Others
4.3 Market Forecast of Therapeutic Nuclear Medicines in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
5.1 South America Economy Situation and Trend Overview
5.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Therapeutic Nuclear Medicines in South America by Major Players
6.2 Revenue of Therapeutic Nuclear Medicines in South America by Major Players
6.3 Basic Information of Therapeutic Nuclear Medicines by Major Players
6.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Players
6.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardinal Health
7.1.1 Company profile
7.1.2 Representative Therapeutic Nuclear Medicines Product
7.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
7.2 Mallkrodt Plc
7.2.1 Company profile
7.2.2 Representative Therapeutic Nuclear Medicines Product
7.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
7.3 GE Healthcare
7.3.1 Company profile
7.3.2 Representative Therapeutic Nuclear Medicines Product
7.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Lantheus Medical Imaging
7.4.1 Company profile
7.4.2 Representative Therapeutic Nuclear Medicines Product
7.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Therapeutic Nuclear Medicines Product
7.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Bracco Imaging SpA
7.6.1 Company profile
7.6.2 Representative Therapeutic Nuclear Medicines Product
7.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
7.7 Eczacibasi-Monrol Nuclear Products
7.7.1 Company profile
7.7.2 Representative Therapeutic Nuclear Medicines Product
7.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
7.8 Nordion
7.8.1 Company profile
7.8.2 Representative Therapeutic Nuclear Medicines Product
7.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
7.9 Advanced Accelerator Applications SA
7.9.1 Company profile
7.9.2 Representative Therapeutic Nuclear Medicines Product
7.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
7.10 IBA Molecular Imaging
7.10.1 Company profile
7.10.2 Representative Therapeutic Nuclear Medicines Product
7.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
8.1 Industry Chain of Therapeutic Nuclear Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
9.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
9.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
9.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
9.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 South America Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Therapeutic Nuclear Medicines in South America 2013-2017
2.2 Consumption Market of Therapeutic Nuclear Medicines in South America by Regions
2.2.1 Consumption Volume of Therapeutic Nuclear Medicines in South America by Regions
2.2.2 Revenue of Therapeutic Nuclear Medicines in South America by Regions
2.3 Market Analysis of Therapeutic Nuclear Medicines in South America by Regions
2.3.1 Market Analysis of Therapeutic Nuclear Medicines in Brazil 2013-2017
2.3.2 Market Analysis of Therapeutic Nuclear Medicines in Argentina 2013-2017
2.3.3 Market Analysis of Therapeutic Nuclear Medicines in Venezuela 2013-2017
2.3.4 Market Analysis of Therapeutic Nuclear Medicines in Colombia 2013-2017
2.3.5 Market Analysis of Therapeutic Nuclear Medicines in Others 2013-2017
2.4 Market Development Forecast of Therapeutic Nuclear Medicines in South America 2018-2023
2.4.1 Market Development Forecast of Therapeutic Nuclear Medicines in South America 2018-2023
2.4.2 Market Development Forecast of Therapeutic Nuclear Medicines by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Therapeutic Nuclear Medicines in South America by Types
3.1.2 Revenue of Therapeutic Nuclear Medicines in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Therapeutic Nuclear Medicines in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Therapeutic Nuclear Medicines in South America by Downstream Industry
4.2 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Brazil
4.2.2 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Argentina
4.2.3 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Venezuela
4.2.4 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Colombia
4.2.5 Demand Volume of Therapeutic Nuclear Medicines by Downstream Industry in Others
4.3 Market Forecast of Therapeutic Nuclear Medicines in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
5.1 South America Economy Situation and Trend Overview
5.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 6 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Therapeutic Nuclear Medicines in South America by Major Players
6.2 Revenue of Therapeutic Nuclear Medicines in South America by Major Players
6.3 Basic Information of Therapeutic Nuclear Medicines by Major Players
6.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Players
6.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Cardinal Health
7.1.1 Company profile
7.1.2 Representative Therapeutic Nuclear Medicines Product
7.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
7.2 Mallkrodt Plc
7.2.1 Company profile
7.2.2 Representative Therapeutic Nuclear Medicines Product
7.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
7.3 GE Healthcare
7.3.1 Company profile
7.3.2 Representative Therapeutic Nuclear Medicines Product
7.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Lantheus Medical Imaging
7.4.1 Company profile
7.4.2 Representative Therapeutic Nuclear Medicines Product
7.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Therapeutic Nuclear Medicines Product
7.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Bracco Imaging SpA
7.6.1 Company profile
7.6.2 Representative Therapeutic Nuclear Medicines Product
7.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
7.7 Eczacibasi-Monrol Nuclear Products
7.7.1 Company profile
7.7.2 Representative Therapeutic Nuclear Medicines Product
7.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
7.8 Nordion
7.8.1 Company profile
7.8.2 Representative Therapeutic Nuclear Medicines Product
7.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
7.9 Advanced Accelerator Applications SA
7.9.1 Company profile
7.9.2 Representative Therapeutic Nuclear Medicines Product
7.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
7.10 IBA Molecular Imaging
7.10.1 Company profile
7.10.2 Representative Therapeutic Nuclear Medicines Product
7.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
8.1 Industry Chain of Therapeutic Nuclear Medicines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
9.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
9.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
9.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
9.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 10 MARKETING STATUS ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
